首页> 美国卫生研究院文献>Cancer Medicine >Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?

【2h】

Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?

机译：接受新辅助化疗与辅助化疗的乳腺癌患者的治疗时间：术前化疗是否有效？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Delays in times to surgery, chemotherapy, and radiotherapy impair survival in breast cancer patients. Neoadjuvant chemotherapy (NAC) confers equivalent survival to adjuvant chemotherapy (AC), but it remains unknown which approach facilitates faster initiation and completion of treatment.

机译：手术，化学疗法和放射疗法的时间延迟会损害乳腺癌患者的生存。新辅助化疗（NAC）与辅助化疗（AC）具有同等的生存率，但仍不清楚哪种方法可促进更快的开始和完成治疗。

著录项

期刊名称 Cancer Medicine
作者
Nicole M. Melchior; Darren B. Sachs; Gabrielle Gauvin; Cecilia Chang; Chihsiung E. Wang; Elin R. Sigurdson; John M. Daly; Allison A. Aggon; Shelly B. Hayes; Elias I. Obeid; Richard J. Bleicher;
展开▼
作者单位

展开▼
年(卷),期 2020(9),8
年度 2020
页码 -1
总页数 10
原文格式 PDF
正文语种
中图分类肿瘤学 ;
关键词
breast cancer; cancer management; neoadjuvant chemotherapy; surgery;

机译：乳腺癌;癌症治疗;新辅助化疗;手术;

相似文献

外文文献
中文文献
专利

1. Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy? [J] . Nicole M. Melchior, Darren B. Sachs, Gabrielle Gauvin, Cancer Medicine . 2020 ,第8期

机译：乳腺癌患者治疗时间接受Neoadjuvant对辅助化疗：效率是术前化疗的效果吗？
2. A Comparison of Proposed Biosimilar LA-EP2006 and Reference Pegfilgrastim for the Prevention of Neutropenia in Patients With Early-Stage Breast Cancer Receiving Myelosuppressive Adjuvant or Neoadjuvant Chemotherapy: Pegfilgrastim Randomized Oncology (Supportive Care) Trial to Evaluate Comparative Treatment (PROTECT-2), a Phase III, Randomized, Double-Blind Trial [J] . Blackwell Kimberly, Donskih Roman, Jones C. Michael, The oncologist . 2016 ,第7期

机译：拟议的生物仿制药LA-EP2006与参考培格非司亭预防早期乳腺癌接受骨髓抑制辅助或新辅助化疗的中性粒细胞减少症的比较：培格非司亭随机肿瘤治疗（支持治疗）以评估比较治疗（PROTECT-2），a第三阶段，随机双盲试验
3. A Comparison of Proposed Biosimilar LA-EP2006 and Reference Pegfilgrastim for the Prevention of Neutropenia in Patients With Early-Stage Breast Cancer Receiving Myelosuppressive Adjuvant or Neoadjuvant Chemotherapy: Pegfilgrastim Randomized Oncology (Supportive Care) Trial to Evaluate Comparative Treatment (PROTECT-2), a Phase III, Randomized, Double-Blind Trial [J] . Kimberly Blackwell, Roman Donskih, C. Michael Jones, The oncologist . 2016 ,第7期

机译：拟议的生物仿制药LA-EP2006与参考培格非司亭用于预防早期接受骨髓抑制或新辅助化疗的乳腺癌中性粒细胞减少症的比较：培格非司亭随机肿瘤治疗（支持治疗）以评估比较治疗（PROTECT-2），a第三阶段，随机双盲试验
4. Breast MRI radiomics for the pre-treatment prediction of response to neoadjuvant chemotherapy in node-positive breast cancer patients [C] . Karen Drukker, Iman El-Bawab, Alexandra Edwards, SPIE Conference on Computer-Aided Diagnosis . 2019

机译：乳腺MRI辐射射清，用于节点阳性乳腺癌患者对新辅助化疗的反应预处理预测
5. The Effects of Adjuvant Chemotherapy on Brain Function in Breast Cancer Patients and a Cancer-Chemotherapy Rodent Model. [D] . Barr, Alicia Thomas. 2014

机译：辅助化疗对乳腺癌患者脑功能的影响和癌症化学疗法的啮齿动物模型。
6. Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single-center experience [O] . Bhavana Bhatnagar, Steven Gilmore, Olga Goloubeva, -1

机译：新辅助或辅助设置下接受化疗的乳腺癌患者因化疗引起的周围神经病变而导致的化疗剂量减少：单中心经验
7. Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy? [O] . Nicole M. Melchior, Darren B. Sachs, Gabrielle Gauvin, 2020

机译：乳腺癌患者治疗时间接受Neoadjuvant对辅助化疗：效率是术前化疗的效果吗？

Treatment times in breast cancer patients receiving neoadjuvant vs adjuvant chemotherapy: Is efficiency a benefit of preoperative chemotherapy?

摘要

著录项

相似文献

相关主题

期刊订阅